SEGMENT RESULTS - Schedule of Reportable Segments Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) segment	Mar. 31, 2022 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment	4
Segment Reporting Information
Total net revenues from external customers	$ 515,267	$ 652,259
Total segment adjusted income from continuing operations before income tax	234,389	339,683
Branded Pharmaceuticals
Segment Reporting Information
Total net revenues from external customers	197,573	204,861
Total segment adjusted income from continuing operations before income tax	96,265	77,666
Sterile Injectables
Segment Reporting Information
Total net revenues from external customers	101,255	240,028
Total segment adjusted income from continuing operations before income tax	41,090	191,254
Generic Pharmaceuticals
Segment Reporting Information
Total net revenues from external customers	198,180	185,944
Total segment adjusted income from continuing operations before income tax	91,687	66,382
International Pharmaceuticals
Segment Reporting Information
Total net revenues from external customers	18,259	21,426
Total segment adjusted income from continuing operations before income tax	$ 5,347	$ 4,381